Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium

• Published in: Wellcome open research 2024, Vol.9, p.181
• Main Authors: Nhu, Le Nguyen Truc, Chambers, Mary, Chantratita, Narisara, Cheah, Phaik Yeong, Day, Nicholas P J, Dejnirattisai, Wanwisa, Dunachie, Susanna J, Grifoni, Alba, Hamers, Raph L, Hill, Jennifer, Jones, E Yvonne, Klenerman, Paul, Mongkolsapaya, Juthathip, Screaton, Gavin, Sette, Alessandro, Stuart, David I, Tan, Chee Wah, Thwaites, Guy, Thanh, Vu Duy, Wang, Lin-Fa, Tan, Le Van
• Format: Article
• Language: English
• Subjects: eng; Open Letter; pandemic responses; SARS-CoV-2 variants
• ISSN: 2398-502X; 2398-502X
• DOI: 10.12688/wellcomeopenres.20742.1

A strong and effective COVID-19 and future pandemic responses rely on global efforts to carry out surveillance of infections and emerging SARS-CoV-2 variants and to act accordingly in real time. Many countries in Southeast Asia lack capacity to determine the potential threat of new variants, or other emerging infections. Funded by Wellcome, the Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium aims to develop and apply a multidisciplinary research platform in Southeast Asia (SEA) for rapid assessment of the biological significance of SARS-CoV-2 variants, thereby informing coordinated local, regional and global responses to the COVID-19 pandemic. Our proposal is delivered by the Vietnam and Thailand Wellcome Africa Asia Programmes, bringing together a multidisciplinary team in Indonesia, Thailand and Vietnam with partners in Singapore, the UK and the USA. Herein we outline five work packages to deliver strengthened regional scientific capacity that can be rapidly deployed for future outbreak responses.